Cardiovascular Assay

The knowledge of the mechanisms and drug response are essential for the development and assessment of new chemical entities for different kinds of cardiovascular diseases. Current drug therapies alleviate symptoms for only 50 to 70% of cardiovascular disease patients and often with unwanted side effects. Cardiotoxicity remains a major concern during drug development, with increased proarrhythmic potential being the main culprit. The pharmaceutical industry is challenged by the growing cost of research and development, and cannot afford drug attrition in late phases of development or withdrawals of approved drugs. Thus, there is an urgent need for extensive research effort and better treatment options to develop novel therapeutic strategies for cardiovascular diseases.

		From	To	From	To	From	To
Monday	Open	9:00am	5:00pm
Tuesday	Open	9:00am	5:00pm
Wednesday	Open	9:00am	5:00pm
Thursday	Open	9:00am	5:00pm
Friday	Open	9:00am	5:00pm
Saturday	Open	9:00am	5:00pm
Sunday	Open